Form 4: iRhythm Technologies Executive Sumi Shrishrimal Reports Stock Transactions

EVP and Chief Risk Officer of iRhythm Technologies, Sumi Shrishrimal, reports multiple transactions involving company stock, including acquisitions through the employee stock purchase plan and sales to cover tax obligations.

Summary

• Sumi Shrishrimal, EVP and Chief Risk Officer of iRhythm Technologies, reported several transactions related to the company's stock.
• She acquired shares through the company's Employee Stock Purchase Plan (ESPP) at prices of $72.49, $74.98, and $71.46 on November 30, 2023, May 31, 2024, and November 29, 2024, respectively.
• She also acquired 15,293 shares on February 25, 2025, and 6,732 shares on February 26, 2025, related to performance Restricted Stock Units (RSUs).
• On February 26, 2025, she sold 7,942 shares at $112.13 to cover tax withholding obligations related to the vesting of these RSUs.
• Following these transactions, Ms. Shrishrimal beneficially owns 37,843 shares of iRhythm Technologies stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The ESPP participation and RSU vesting are positive indicators, while the sale of shares is a neutral event related to tax obligations.

Positives

• The executive's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.
• The vesting of performance-based RSUs suggests that performance goals were met.

Negatives

• The sale of shares to cover tax obligations, while common, slightly reduces the executive's stake in the company.

Future Outlook

The vesting schedule of the RSUs indicates continued service is required for full vesting, suggesting a long-term commitment from the executive.

Industry Context

Executive stock transactions are common and are often scrutinized by investors for insights into management's view of the company's prospects. ESPP participation is generally seen as a positive sign, while sales can be interpreted in various ways, including personal financial planning.

Comparison to Industry Standards

• Executive compensation packages often include RSUs that vest over time, aligning management's interests with shareholders.
• Sales of shares to cover tax obligations are a standard practice among executives receiving equity compensation.
• Comparing the size of the RSU grants and ESPP participation to those of executives at similar-sized medical technology companies (e.g., Dexcom, Insulet) could provide a benchmark for assessing the competitiveness of iRhythm's compensation practices.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect routine executive compensation and tax planning.
• Employees participating in the ESPP benefit from the opportunity to purchase company stock at potentially favorable prices.

Next Steps

• Monitor future Form 4 filings to track changes in the executive's ownership and potential insights into company performance.

Key Dates